China Active Pharmaceutical Ingredient (API) Market Overview, 2027

China API Market Size, Share, Trend & Market Analysis By Type, By Distribution Channel, By End User, Competition, Forecast & Opportunities.

"China is the largest manufacturer of chemical API in the market and exports API to 189 countries and regions in Asia, Europe, and North America. China has emerged as a leading global player in this sector due to several factors, including low production costs, a vast chemical manufacturing infrastructure, and a large pool of skilled labor. The country's API industry has experienced significant growth and development over the past few decades. Chinese API manufacturers, along with global stakeholders, are placing increased emphasis on diversifying supply chains, ensuring redundant capacities, and building robust contingency plans to mitigate future disruptions. Chinese API manufacturers are actively seeking collaborations and partnerships with international pharmaceutical companies, contract manufacturing organizations (CMOs), and research institutions. Chinese API manufacturers are recognizing this trend and are investing in biopharmaceutical capabilities, such as cell culture technologies and bioprocessing facilities, to cater to the increasing demand for these products. Data analytics, AI, and Internet of Things (IoT) technologies are being used by manufacturers to streamline production procedures, boost productivity, and ensure real-time monitoring and management of industrial activities. The use of nanotechnology in medication delivery systems is being investigated by Chinese API makers. The creation of cutting-edge pharmaceutical formulations now has more avenues for growth thanks to this invention. According to the report titled ""China Active Pharmaceutical Ingredients Market Overview, 2027"", published by Bonafide Research, the market is expected to grow exorbitantly over the forecast period. Though synthetic APIs are widely used to manufacture drugs, biotech APIs are expected to grow rapidly over the forecast period. This is due to the launches of new drugs and biological products, acquisitions, collaborations, and regional expansion initiatives being taken by the companies to maintain stability in the market. The captive segment has the largest market share and is anticipated to grow in the future owing to the easy availability of raw materials and huge investments by major companies to develop high-end manufacturing facilities. Recent advancements and research suggest that companies are more focused on in-house manufacturing than outsourcing to others. The captive API segment accounted for the major market share and is expected to grow at a steady CAGR over the forecast period. Generic APIs are expected to be in demand over the forecast period as the branded API segment's demands are declining. This is due to the consolidation in the pharma industry and various drugs going off-patent. Due to a rise in over-the-counter drugs and the lower cost of generic drugs, it is expected to lure consumers. The increasing obesity, diabetes, and other chronic diseases, which are long-lasting and require the patient to consume the drugs on a daily basis, drive the demand for cheaper alternatives to save costs. Thus, the demand for generic API will rise in future years coupled with government incentives.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The cardiovascular diseases segment accounts for the largest application due to increasing heart-related diseases worldwide. Rising awareness, preventive treatment, and government measures are further expected to drive future demand for API. On the other hand, oncology applications are expected to grow rapidly over the forecast period due to the changing lifestyles of Millennials and the growing number of cancer patients in recent years. The metabolic disorders caused by sedentary lifestyles and hormonal imbalances created in the human body are the factors increasing the risks of these diseases. Diabetes is another chronic disease that is on the rise among the populace in the country. Though synthetic APIs led the market, biotech APIs are expected to grow rapidly in the forecast period owing to increased demand for biopharmaceuticals and the number of innovations in the field to meet medical needs for various diseases. It is considered to be a highly profitable segment that has attracted many key players to invest in these manufacturing facilities. The FDA approvals for vaccines, blood components, and recombinant proteins are further expected to boost market growth. Many companies are now focusing exclusively on producing biological drugs as it is a lucrative market. COVID-19 Impact: The pandemic had a combination of effects on the API market, creating demand shocks across the world, but some drugs that were required to treat the virus' effects were in huge demand. There was an increased demand for fever, cold, and cough drugs. In 2020 it decreased by -2.80% due to supply chain logistics which were at a standstill. However, the future markets are projected to grow exorbitantly as they have recovered from the pandemic shocks. Many manufacturing units in China were shut down due to a lack of raw materials and the pandemic effects which affected the world markets for API. Also, the decrease in demand for pharmaceuticals for certain elective procedures has also led to a decline in the market's growth in 2020. The sales declined also because the supply chain logistics were at a standstill due to immobility. Although the demand for drugs like paracetamol, azithromycin, and hydroxychloroquine is up, the demand for them is down. To treat the symptoms and numerous health conditions that a COVID-19 patient may have, such as cough, cold, and high fever, a variety of medications are employed, leading to the pharmaceutical industry being the epicenter of the pandemic. API manufacturers in China are pursuing to meet the growing demand for pharmaceutical products. The industry continues to evolve and adapt to advancements in science, technology, and patient needs. API manufacturers are increasingly partnering with research institutions, startups, and other industry stakeholders to foster collaboration and open innovation. By sharing knowledge, resources, and expertise, they can accelerate the development of new ideas and bring innovative products to market more rapidly. API manufacturers are also using new technologies, such as artificial intelligence (AI) and machine learning, to improve their manufacturing processes. These technologies are used to optimize process parameters, predict yields, and identify potential problems Considered in this report ? Geography: United States (US) ? Historic Year: 2016 ? Base year: 2021 ? Estimated year: 2022 ? Forecast year: 2027

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

Aspects covered in this report United States • Active Pharmaceutical Ingredients Market with its value, forecast, and segments • Application wise Active Pharmaceutical Ingredients distribution • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Based on a synthesis of Active Pharmaceutical Ingredients in the report • Synthetic API • Biotech API Based on the drug type of Active Pharmaceutical Ingredients in the report • Branded API • Generic API

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

Based on the type of manufacture of Active Pharmaceutical Ingredients in the report • Captive API • Merchant API By Therapeutic Application Type in the report • Communicable Diseases • Oncology • Diabetes • Cardiovascular Disease • Pain management • Respiratory Diseases • Other Therapeutic Applications The approach of the report This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual reports of companies, and analyzing government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the pharmaceutical industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry. Please get in touch with our sales team to find out more."

Table of Contents

  • Table of Content
  • 1. Executive Summary
  • 2. Introduction
  • 2.1. Market Definition
  • 2.2. Market Scope & Segmentation
  • 2.3. Research Methodology
  • 3. China Macro Economic Indicators
  • 4. China Active Pharmaceutical Ingredients Market Category Analysis
  • 4.1. Key findings
  • 4.2. Market Drivers
  • 4.3. Market Restraints
  • 4.4. Policies & Certification
  • 4.5. Opportunities
  • 4.6. Value Chain Analysis
  • 4.7. Key Developments - 2021
  • 5. China Active Pharmaceutical Ingredients Market Trends
  • 6. China Active Pharmaceutical Ingredients Market Overview
  • 6.1. Market Size By Value
  • 6.2. Market Share
  • 6.2.1. By Synthesis Type
  • 6.2.2. By Therapeutic Application
  • 6.2.3. By Type of Manufacture
  • 7. China Active Pharmaceutical Ingredients Market Segmentations
  • 7.1. China Active Pharmaceutical Ingredients Market, By Synthesis Type
  • 7.1.1. China Active Pharmaceutical Ingredients Market Size, By Synthetic API, 2016 - 2027F
  • 7.1.2. China Active Pharmaceutical Ingredients Market Size, By Biotech API, 2016 - 2027F
  • 7.2. China Active Pharmaceutical Ingredients Market, By Therapeutic Application
  • 7.2.1. China Active Pharmaceutical Ingredients Market Size, By Communicable Diseases, 2016 - 2027F
  • 7.2.2. China Active Pharmaceutical Ingredients Market Size, By Oncology, 2016 - 2027F
  • 7.2.3. China Active Pharmaceutical Ingredients Market Size, By Diabetes, 2016 - 2027F
  • 7.2.4. China Active Pharmaceutical Ingredients Market Size, By Cardiovascular Disease, 2016 - 2027F
  • 7.2.5. China Active Pharmaceutical Ingredients Market Size, By Pain management, 2016 - 2027F
  • 7.2.6. China Active Pharmaceutical Ingredients Market Size, By Respiratory Diseases, 2016 - 2027F
  • 7.2.7. China Active Pharmaceutical Ingredients Market Size, By Other Therapeutic Applications, 2016 - 2027F
  • 7.3. China Active Pharmaceutical Ingredients Market, By Type of Manufacture
  • 7.3.1. China Active Pharmaceutical Ingredients Market Size, By Captive API, 2016 - 2027F
  • 7.3.2. China Active Pharmaceutical Ingredients Market Size, By Merchant API, 2016 - 2027F
  • 8. China Active Pharmaceutical Ingredients Market Opportunity Assessment
  • 8.1. By Active Pharmaceutical Ingredients, 2022F to 2027F
  • 8.2. By Therapeutic Application, 2022F to 2027F
  • 8.3. By Type of Manufacture, 2022F to 2027F
  • 9. Competitive Landscape
  • 9.1. Porter's Five Forces
  • 9.2. Company Profiles
  • 9.2.1. Company 1
  • 9.2.2. Company 2
  • 9.2.3. Company 3
  • 9.2.4. Company 4
  • 9.2.5. Company 5
  • 9.2.6. Company 6
  • 9.2.7. Company 7
  • 9.2.8. Company 8
  • 10. Strategic Recommendations
  • 11. Disclaimer

List of Table
Table 1: China Active Pharmaceutical Ingredients Market Size of Synthetic API (2016 to 2027F) (In USD billion)
Table 2: China Active Pharmaceutical Ingredients Market Size of Biotech API (2016 to 2027F) (In USD billion)
Table 3: China Active Pharmaceutical Ingredients Market Size of Communicable Diseases (2016 to 2027F) (In USD billion)
Table 4: China Active Pharmaceutical Ingredients Market Size of Oncology (2016 to 2027F) (In USD billion)
Table 5: China Active Pharmaceutical Ingredients Market Size of Diabetes (2016 to 2027F) (In USD billion)
Table 6: China Active Pharmaceutical Ingredients Market Size of Cardiovascular Disease (2016 to 2027F) (In USD billion)
Table 7: China Active Pharmaceutical Ingredients Market Size of Pain management (2016 to 2027F) (In USD billion)
Table 8: China Active Pharmaceutical Ingredients Market Size of Respiratory Diseases (2016 to 2027F) (In USD billion)
Table 9: China Active Pharmaceutical Ingredients Market Size of Other Therapeutic Applications (2016 to 2027F) (In USD billion)
Table 10: China Active Pharmaceutical Ingredients Market Size of Captive API (2016 to 2027F) (In USD billion)
Table 11: China Active Pharmaceutical Ingredients Market Size of Merchant API (2016 to 2027F) (In USD billion)
Table 12: Key Facts of Company 1
Table 13: Key Facts of Company 2
Table 14: Key Facts of Company 3
Table 15: Key Facts of Company 4
Table 16: Key Facts of Company 5
Table 17: Key Facts of Company 6
Table 18: Key Facts of Company 7
Table 19: Key Facts of Company 8

List of Figure
Figure 1: China Active Pharmaceutical Ingredients Market Size By Value 2016 to 2027F (In USD billion)
Figure 2: China Active Pharmaceutical Ingredients Market Share By Volume By Synthesis Type (2016, 2021 & 2027F)
Figure 3: China Active Pharmaceutical Ingredients Market Share By Volume By Therapeutic Application (2016, 2021 & 2027F)
Figure 4: China Active Pharmaceutical Ingredients Market Share By Type of Manufacture (2016, 2021 & 2027F)
Figure 5: Market Attractiveness Index, By Synthesis Type
Figure 6: Market Attractiveness Index, By Therapeutic Application
Figure 7: Market Attractiveness Index, By Type of Manufacture
Figure-8: Porter's Five Forces Meter of Active Pharmaceutical Ingredients Industry in China

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

China Active Pharmaceutical Ingredient (API) Market Overview, 2027

We are friendly and approachable, give us a call.